Development of group B meningococcal vaccine: a progress review
Epidemic cerebrospinal meningitis is a respiratory infectious disease caused by Neisseria meningitidis, most commonly manifesting as meningitis and septicaemia. Due to the lack of effective prevention measures, serogroup B Neisseria meningitidis (MenB) has become one of dominant epidemic bacterial g...
Saved in:
Main Authors: | Wei ZHAO (Author), Shuang BAI (Author), Yan-li KANG (Author) |
---|---|
Format: | Book |
Published: |
Editorial Office of Chinese Journal of Public Health,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in meningococcal conjugate vaccine development and use
Published: (2020) -
Impact of meningococcal group B OMV vaccines, beyond their brief
by: Helen Petousis-Harris
Published: (2018) -
Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
by: María Fernández-Prada, et al.
Published: (2018) -
Localized hypertrichosis after meningococcal B vaccine
by: Rita Pessoa-Coutinho, et al.
Published: (2023) -
Meningococcal serogroup B vaccines: Estimating breadth of coverage
by: Robert G. K. Donald, et al.
Published: (2017)